Background: Acute kidney injury (AKI) is a common morbidity after off-pump coronary revascularization. We investigated whether perioperative administration of sodium bicarbonate, which might reduce renal injury by alleviating oxidative stress in renal tubules, prevents postoperative AKI in off-pump coronary revascularization patients having renal risk factors. Methods: Patients (n=162) having at least one of the following AKI risk factors were enrolled: (i) age >70 yr; (ii) diabetes mellitus; (iii) chronic renal disease; (iv) congestive heart failure or left ventricular ejection fraction <35%; and (v) reoperation or emergency. Patients were evenly randomized to receive either sodium bicarbonate (0.5 mmol kg −1 for 1 h upon induction of
Editors' key points
• Previous studies show that sodium bicarbonate administration might protect the kidneys.
• The authors thus performed a randomized controlled trial among patients undergoing off-pump coronary revascularization.
• Included patients had one or more risk factors for acute kidney injury.
• Sodium bicarbonate use did not reduce the incidence of kidney injury.
Acute kidney injury (AKI) is a frequent complication of cardiac surgery that adversely affects prognosis. 1 2 Unfortunately, there are no established treatments for AKI, and research is focused mainly on the prevention of AKI.
The pathogenesis of cardiac surgery-induced AKI is complex, and apart from the patient's risk factors, it has been predominantly attributed to cardiopulmonary bypass (CPB)-induced systemic inflammation, ischaemia-reperfusion injury, haemolysis, and microembolism. 3 Nonetheless, despite the avoidance of CPB, the incidence of postoperative AKI is not reduced in offpump coronary bypass surgery (OPCAB) relative to on-pump surgeries. 4 Off-pump coronary bypass surgery involves inevitable periods of heart displacement and regional myocardial ischaemia-reperfusion injury causing haemodynamic deterioration, 5 thereby exposing the kidney to oxidative stress. Sodium bicarbonate infusion has a renoprotective effect by reducing oxidative stress in renal tubular cells. [6] [7] [8] The proposed mechanisms include attenuation of free radical generation, direct peroxynitrite scavenging, and urinary alkalinization. 7 9 In conjunction, a pilot study in cardiac surgical patients undergoing CPB showed renoprotective effects of sodium bicarbonate infusion. 10 In order to attenuate contrast-induced AKI, in which oxidative stress also plays a major role as in AKI after OPCAB, the recent guideline by the Acute Kidney Injury Work Group and Canadian Association of Radiologists recommends i.v. bicarbonate infusion. 11 In contrast, several trials have reported that i.v. bicarbonate infusion failed to prevent AKI after cardiac surgery 12 or contrast-induced AKI in high-risk patients. 13 So far, evidence regarding the renoprotective effect of sodium bicarbonate seems inconsistent, depending on the clinical scenario. Nonetheless, despite a high prevalence of AKI after OPCAB, renoprotective efficacy of sodium bicarbonate in OPCAB has not previously been addressed.
In this double-blind randomized controlled trial, we investigated whether perioperative i.v. sodium bicarbonate administration reduces the occurrence of postoperative AKI in OPCAB patients having renal risk factors.
Methods
The present study was registered at clinicaltrials.gov (NCT01840241) after approval by the institutional review board. All participants gave written informed consent before their surgeries. Patient flow is reported using the Consolidated Standards of Reporting Trials (CONSORT) recommendation. Patients undergoing elective OPCAB were included when they had one or more of the following risk factors: (i) advanced age (>70 yr); (ii) diabetes mellitus; (iii) congestive heart failure, defined as New York Heart Association class ≥III or low left ventricular ejection fraction (<35%); (iv) pre-existing chronic renal disease (estimated glomerular filtration rate using modification of diet in renal disease formula ). Between April 2013 and September 2015, 162 patients were evenly randomized to the sodium bicarbonate or the control group by a computer-generated randomization list using a permuted two-block strategy. Concealment of group allocation to attending physicians, intensivists, nurses, patients, and investigators was ensured by using non-transparent envelopes. Envelopes were opened on the morning of surgery by an anaesthetic nurse who was not involved in the patient's care, who would prepare 154 mequiv l −1 of sodium bicarbonate in H 2 O or 0.9% sodium chloride according to the group allocation.
Intervention and study protocol
After the insertion of a pulmonary artery catheter, patients in the sodium bicarbonate group received an i.v. dose of 0.5 mmol kg 14 Proximal anastomosis at the ascending aorta was carried out without side-clamping using the Heartstring Proximal Seal System (Guidant, Indianapolis, IN, USA) after visual confirmation by epiaortic ultrasonography. During surgery, patients received balanced crystalloid (Plasma solution A 1000 inj; CJ, Seoul, Korea) at 6 ml kg −1 h −1 , and balanced synthetic colloid (Volulyte; Fresenius Kabi, Bad Homburg, Germany) was infused to replace estimated blood loss at a maximal dose of 1000 ml. Intraoperative blood loss was estimated by the amount of collected blood through a cell-saving device, which was infused into the patient before leaving the operating room. Target mean arterial pressure (MAP) was >70 mm Hg, which was achieved by norepinephrine infusion and a 5-10°T rendelenburg position during grafting. Subsequently, vasopressin was added if the target MAP could not be achieved, in a stepwise additive fashion. Milrinone (0.5 µg kg −1 min −1 ) was infused when there was a persistent decrease in mixed venous oxygen saturation (Sv O2 <60% for more than 10 min) or newly developed severe (grade ≥3) mitral regurgitation. Allogeneic packed erythrocytes ( pRBCs) were transfused when the haematocrit was decreased to <25% throughout the study period. After surgery, all participants were managed in the intensive care unit (ICU) by the institutional standardized protocols, which are as follows. In brief, crystalloid solution at 2-3 ml kg −1 h −1 was infused for maintenance. Blood loss (amount of chest tube drainage) was replaced either with colloid solution (<20 ml kg
or with pRBCs depending on the haematocrit targeted at ≥25%. 
Outcome measures
The primary outcome measure was to assess the incidence of AKI, which was diagnosed as >50% or ≥0.3 mg dl −1 increase in serum creatinine from baseline during 48 h after surgery. 15 16 Secondary outcome measures were the requirement for renal replacement therapy during first 2 days after surgery and the calculated number of patients with AKI at the various stages of the Acute Kidney Injury Network classifications (AKIN stages 1, 2, and 3), 16 and the incidence of major postoperative morbidity end points (permanent stroke, mechanical ventilation >24 h, myocardial infarction, reoperation, deep sternal wound infection, and atrial fibrillation). Serum creatinine, cystatin C, pH, K + , Na + , and HCO 3 − were measured before surgery (baseline) and at 24 and 48 h after surgery. Serum pH, K + , Na + , and HCO 3 − were also measured immediately before and after grafting. Urine pH was assessed in 10% of enrolled patients, because adequate urinary alkalinization had been consistently demonstrated using the same protocol of i.v. sodium bicarbonate in previous studies. 10 17 The preoperative variables assessed were as follows: patient characteristics; chronic obstructive pulmonary disease; diabetes mellitus, hypertension, congestive heart failure, left ventricular ejection fraction, myocardial
Assessed for eligibility (n=577)
415 not eligible or no consent ), and alkalaemia ( pH >7.5) were also recorded for 48 h after surgery.
Statistical analysis
Given that we enrolled patients with renal risk factors, the incidence of postoperative AKI in the control group was expected to be 40%, 19 20 and sodium bicarbonate would reduce it to 20%. Accordingly, sample size calculation revealed that 81 patients in each group would yield a statistical power of 80% at an α-value of 0.05. Data are presented as the median (interquartile range), mean () or number of patients ( percentage). Numerical data were tested for normality using the Kolmogorov-Smirnov test and analysed by an independent Mann-Whitney U-test or independent t-test as appropriate. Categorical data analyses were performed using Fisher's exact test or the χ 2 test where appropriate. Serial laboratory data were compared between groups using a linear mixed model. Values of P<0.05 were considered statistically significant, except for Bonferroni corrected P-values in post hoc tests for serial laboratory data analysis. Analysis was performed using SPSS, version 18.0 (SPSS Inc., Chicago, IL, USA).
Results
The data of all 162 patients could be analysed (Fig. 1) , and none of the patients required an emergency conversion to an on-pump procedure. Patient characteristics were comparable between the two groups, except for the use of calcium channel blockers ( Table 1) .
The incidences of AKI were 21% in the bicarbonate group and 26% in the control group (P=0.458; Table 2 ). There were no differences in proportions of AKIN stages (Table 2) . Serum creatinine concentrations and cystatin C concentrations measured at 24 and 48 h after the surgery were also similar between the groups, and both were not significantly different in the two groups over time (P=0.078 and P=0.968, respectively; Table 2 ).
Serum sodium concentration and urine pH were greater over time in the bicarbonate group (P<0.001 and P=0.001, respectively), whereas the serum potassium concentration was greater over time in the control group (P=0.001). In intergroup comparisons at measurement points, serum sodium concentrations were higher in the bicarbonate group 24 h after the surgery, whereas serum potassium concentrations were higher in the control group immediately after grafting and 24 h after the surgery (Fig. 2) . The incidences of alkalaemia (27 vs 4%, P<0.001) and hypokalaemia (27 vs 12%, P=0.018) were higher in the bicarbonate group relative to the control group.
Intraoperative data, including fluid balance, number of grafts performed, and episodes of low cardiac output during grafting, were similar between the groups. The numbers of patients who received norepinephrine and the amounts infused, and the numbers of patients who required vasopressin infusion, milrinone infusion, or both were also comparable between the groups (Table 3) . Intraoperative haemodynamic variables, including MAP, central venous pressure, pulmonary artery occlusion pressure, cardiac index, and Sv O2 , were similar at any time point and over time between the groups (data not shown).
There were no significant differences in the amounts of fluid balance, urine output, pRBC transfusion requirements, blood loss, furosemide requirement, and cardiac index during the postoperative 48 h. The numbers of patients who required inotropic agents, vasopressors, or both in the ICU were also comparable ( Table 4) .
Durations of ICU stay and postoperative hospitalization, and the incidence of morbidity end points were comparable between the groups except for the number of patients requiring prolonged mechanical ventilation (>24 h), which was significantly higher in the bicarbonate group relative to the control group (20 vs 6, P=0.003).
Discussion
In the present randomized, double-blind controlled trial, perioperative sodium bicarbonate infusion could not attenuate AKI after OPCAB, while the need for prolonged mechanical ventilation was significantly more prevalent in the bicarbonate group relative to the control group.
Despite the theoretical advantage of avoiding CPB, AKI remains the most common morbidity after OPCAB, drawing attention to the need for an effective preventive therapy. 19 Renal perfusion may be at risk during mechanical heart displacement and grafting because they invariably cause cardiac dysfunction, 5 which would elicit oxidative stress in the renal medulla, which is already perfused with blood having low oxygen tension. 21 22 Administration of sodium bicarbonate has been suggested to alleviate the oxidative stress in renal tubular cells. 6 23 24 It may limit free radical generation by slowing the Haber-Weiss reaction and lead to direct scavenging of reactive nitrogen or oxygen species. 23 In addition, urinary alkalization may inhibit hydroxyl radical generation when the concentration of free haemoglobin or myoglobin exceeds the binding capacity of haptoglobin. 25 Accordingly, use of sodium bicarbonate has been advocated to prevent the development of contrast-induced AKI where oxidative stress plays a pivotal role. 26 Nonetheless, studies involving cardiac surgery patients undergoing CPB have reported conflicting results regarding the renoprotective effect of sodium bicarbonate. 10 12 17 27 Moreover, concerns have been expressed about the possibility of increased risk of AKI or even in-hospital mortality related to sodium bicarbonate infusion, arguing against its routine use in clinical practice. 27 However, the results of two relatively large recent studies showed a limited renoprotective efficacy of sodium bicarbonate only in low-risk cardiac surgery patients 28 and those undergoing coronary bypass surgery. 28 29 It was suggested that AKI worsened in tandem according to the increasing number of risk factors. It was also hypothesized that the increased risk of AKI in other types of cardiac surgeries compared with coronary bypass surgery is associated with more microembolic events and haemolysis, which exceed the capacity of sodium bicarbonate. The pathogenic mechanism of AKI after OPCAB would be more similar to that of contrast-induced AKI, apart from the more intense systemic inflammation in OPCAB, because both are devoid of CPB-related risk factors. Therefore, renal hypoperfusion and oxidative stress would play dominant roles in the development of AKI after OPCAB. Accordingly, we hypothesized that sodium bicarbonate infusion could mitigate the development of postoperative AKI in OPCAB patients having renal risk factors, which has not been evaluated before.
Contrary to our expectations, however, perioperative sodium bicarbonate infusion did not reduce the incidence of AKI after OPCAB in the present study. Moreover, it was related to a significantly higher number of patients requiring prolonged mechanical ventilation. There may be several explanations for the apparent discordance between our findings and the published results. Firstly, enrolment of patients with risk factors for AKI could have affected our results. Although the mean ARF scores in the sodium bicarbonate and control groups were similar, the number of patients with ARF scores higher than 3 points was greater in the sodium bicarbonate group (14 vs 7%, P=0.2). Considering that sodium bicarbonate infusion was effective only in patients with ARF scores of <3 points, 28 this difference could have affected our results. Secondly, more patients taking calcium channel blockers were randomized to receive 0.9% sodium chloride. Calcium channel blockers can potentially reduce tubular cell death during renal ischaemia by preventing the increase in intramitochondrial calcium concentration, selective preglomerular vasodilation, and the restoration of autoregulation in the presence of increased sympathetic tone. 30 Lastly, in previous studies, the inefficiency of sodium bicarbonate in reducing AKI was discussed in view of hypokalaemia and alkalaemia-associated reduced perfusion, 31 increased cell death, apoptosis related to superoxide formation, 32 impaired tissue oxygenation, 33 and hypotension. 27 Alkalaemia may also be associated with respiratory depression and potential worsening of intrapulmonary shunt. 34 35 Although we did not monitor all these aspects, hypokalaemia and alkalaemia were significantly more prevalent in the bicarbonate group. Furthermore, the need for prolonged mechanical ventilation was significantly more prevalent in the bicarbonate group. When comparing the morbidity end points between patients exhibiting alkalaemia or not, the need for prolonged mechanical ventilation was greater (44 vs 11%, P<0.001) and the time to extubation was longer [21.1 (17.7-45.7) vs 17.5 (15.8-20 .0) h, P=0.001] in the alkalaemic patients (data not shown). Although the present study was not sufficiently powered to compare morbidity end points, the potential drawbacks of sodium bicarbonate infusion strongly argue against its use to prevent AKI in this subset of patients until further evidence emerges. This study is subject to the following limitations. Firstly, the overall incidence of AKI was lower than expected (24 vs 40%), limiting the statistical power, and a possible influence of a selection bias cannot be ruled out. Secondly, balanced hydroxyethyl starch 130/0.4 solution was used to compensate for blood loss, which has the potential to influence renal function. However, the mainstay of the fluid therapy was crystalloid solution, and colloid was used only in small amounts. Moreover, the amount of colloid used was similar between the groups, and thus, its influence on the results should be negligible. Thirdly, urinary alkalinization cannot be ensured in all patients because it was assessed in a randomly selected 10% of the studied patients. Lastly, as long as we do not understand the precise mechanism underlying postoperative AKI in OPCAB in patients having renal risk factors, it would be difficult to find any effective renoprotective intervention.
In conclusion, perioperative i.v. sodium bicarbonate administration could not attenuate the occurrence of postoperative AKI in OPCAB in patients having renal risk factors. Furthermore, i.v. sodium bicarbonate administration was associated with more patients requiring prolonged mechanical ventilation. Based on these observations, we argue against its use for the purpose of AKI prevention in this subset of patients. 
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